387. This Month in MedTech: Q1 Earnings, M&A Momentum, and the Rise of Focused Strategics by State of Medtech (opens in new tab)

In this episode of This Month in MedTech, Omar Khateeb speaks with Nicholas Talamantes, Sr. Director at Life Science Intelligence, about the market signals shaping MedTech right now.The discussion covers Q1 earnings from major strategics, the rise of focused growth platforms, Boston Scientific’s $1.5B bet on structural heart, and the latest M&A activity from J&J, Medtronic, ResMed, Roche, and Artivion.Omar and Nicholas also break down why focus is being rewarded in public markets, why large p...